Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04986852
Title Olinvacimab With Pembrolizumab in Patients With mTNBC
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors PharmAbcine
Age Groups: senior | adult
Covered Countries

No variant requirements are available.